SFRS14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.120800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.376800E-01
Normal-vs-Stage2
3.817600E-01
Normal-vs-Stage3
1.332210E-01
Normal-vs-Stage4
2.461200E-01
Stage1-vs-Stage2
2.583000E-01
Stage1-vs-Stage3
1.453650E-01
Stage1-vs-Stage4
3.017800E-01
Stage2-vs-Stage3
1.542830E-01
Stage2-vs-Stage4
7.231400E-01
Stage3-vs-Stage4
4.435800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.286600E-01
Normal-vs-AfricanAmerican
2.855800E-01
Normal-vs-Asian
3.451200E-01
Caucasian-vs-AfricanAmerican
1.407510E-02
Caucasian-vs-Asian
3.461000E-01
AfricanAmerican-vs-Asian
4.071800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.229200E-01
Normal-vs-Female
4.030800E-01
Male-vs-Female
6.761800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.894800E-01
Normal-vs-Age(41-60Yrs)
4.604000E-01
Normal-vs-Age(61-80Yrs)
5.158000E-02
Normal-vs-Age(81-100Yrs)
3.593200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.813400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.918980E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.291200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.752820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.988580E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.972400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.694200E-01
Normal-vs-Daily Drinker
6.545700E-02
Normal-vs-Weekly Drinker
4.083400E-01
Normal-vs-Occasional Drinker
2.181400E-01
Normal-vs-Social Drinker
2.484800E-01
Non Drinker-vs-Daily Drinker
8.481600E-01
Non Drinker-vs-Weekly Drinker
5.996800E-01
Non Drinker-vs-Occasional Drinker
5.080600E-01
Non Drinker-vs-Social Drinker
1.059760E-01
Daily Drinker-vs-Weekly Drinker
5.814200E-01
Daily Drinker-vs-Occasional Drinker
4.619400E-01
Daily Drinker-vs-Social Drinker
1.595040E-01
Weekly Drinker-vs-Occasional Drinker
7.731200E-01
Weekly Drinker-vs-Social Drinker
3.152400E-01
Occasional Drinker-vs-Social Drinker
5.982000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.322200E-01
Normal-vs-Grade 2
8.814000E-02
Normal-vs-Grade 3
1.294610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.148630E-01
Grade 1-vs-Grade 3
1.923410E-01
Grade 1-vs-Grade 4
3.322200E-01
Grade 2-vs-Grade 3
4.759000E-01
Grade 2-vs-Grade 4
8.814000E-02
Grade 3-vs-Grade 4
1.294610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.502800E-01
Normal-vs-NonDiabetic
7.694200E-02
Diabetic-vs-NonDiabetic
1.058570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.890000E-01
Normal-vs-NoPancreatitis
3.966800E-01
Pancreatitis-vs-NoPancreatitis
8.995600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.324000E-01
Normal-vs-N1
3.775000E-01
N0-vs-N1
1.530010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.106400E-01
Normal-vs-TP53-NonMutant
3.299400E-01
TP53-Mutant-vs-TP53-NonMutant
9.157600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
